APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-PD-1 MAb

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Anti-PD-1 MAb Industry Growth and Trends Forecast to 2032

2 January 202687 pages

Choose your research edition.

Industry ResearchAnti-PD-1 MAb Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-PD-1 MAb Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Anti-PD-1 MAb Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-PD-1 MAb Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-PD-1 MAb Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

According to APO Research, the global Anti-PD-1 MAb market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Anti-PD-1 MAb is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Anti-PD-1 MAb is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti-PD-1 MAb is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Anti-PD-1 MAb market include Thermo Fisher Scientific, Merck KGaA, Ximbio, Sino Biological, OriGene Technologies, Leinco Technologies, Elabscience and BioVision, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Anti-PD-1 MAb market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Anti-PD-1 MAb market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Anti-PD-1 MAb market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Anti-PD-1 MAb.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Anti-PD-1 MAb market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Anti-PD-1 MAb Market by Company

Thermo Fisher Scientific

Merck KGaA

Ximbio

Sino Biological

OriGene Technologies

Leinco Technologies

Elabscience

BioVision

Anti-PD-1 MAb Segment by Type

1mg

2.5mg

Others

Anti-PD-1 MAb Segment by Application

Pharmaceutical

Research

Other

Anti-PD-1 MAb Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-PD-1 MAb market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-PD-1 MAb and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-PD-1 MAb.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Anti-PD-1 MAb companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Anti-PD-1 MAb Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Anti-PD-1 MAb Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Anti-PD-1 MAb Market Share by Region (2021-2026) Table 4. Global Anti-PD-1 MAb Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Anti-PD-1 MAb Market Share by Region (2027-2032) Table 6. Global Anti-PD-1 MAb Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Anti-PD-1 MAb Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Anti-PD-1 MAb Market Size Share by Type (2021-2026) Table 9. Global Anti-PD-1 MAb Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Anti-PD-1 MAb Market Size Share Forecasted by Type (2027-2032) Table 11. North America Anti-PD-1 MAb Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Anti-PD-1 MAb Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Anti-PD-1 MAb Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Anti-PD-1 MAb Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Anti-PD-1 MAb Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Anti-PD-1 MAb Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Anti-PD-1 MAb Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Anti-PD-1 MAb Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Anti-PD-1 MAb Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Anti-PD-1 MAb Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Anti-PD-1 MAb Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Anti-PD-1 MAb Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Anti-PD-1 MAb Market Size Share by Application (2021-2026) Table 24. Global Anti-PD-1 MAb Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Anti-PD-1 MAb Market Size Share Forecasted by Application (2027-2032) Table 26. North America Anti-PD-1 MAb Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Anti-PD-1 MAb Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Anti-PD-1 MAb Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Anti-PD-1 MAb Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Anti-PD-1 MAb Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Anti-PD-1 MAb Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Anti-PD-1 MAb Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Anti-PD-1 MAb Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Anti-PD-1 MAb Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Anti-PD-1 MAb Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Anti-PD-1 MAb Industry Trends Table 37. Anti-PD-1 MAb Industry Drivers Table 38. Anti-PD-1 MAb Industry Opportunities and Challenges Table 39. Anti-PD-1 MAb Industry Restraints Table 40. Global Anti-PD-1 MAb Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Anti-PD-1 MAb Revenue Market Share by Company (2021-2026) Table 42. Global Anti-PD-1 MAb Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Anti-PD-1 MAb Key Company Headquarters & Area Served Table 44. Global Anti-PD-1 MAb Company, Product Type & Application Table 45. Global Anti-PD-1 MAb Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Anti-PD-1 MAb by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Thermo Fisher Scientific Company Information Table 49. Thermo Fisher Scientific Business Overview Table 50. Thermo Fisher Scientific Anti-PD-1 MAb Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Thermo Fisher Scientific Anti-PD-1 MAb Product Portfolio Table 52. Thermo Fisher Scientific Recent Development Table 53. Merck KGaA Company Information Table 54. Merck KGaA Business Overview Table 55. Merck KGaA Anti-PD-1 MAb Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Merck KGaA Anti-PD-1 MAb Product Portfolio Table 57. Merck KGaA Recent Development Table 58. Ximbio Company Information Table 59. Ximbio Business Overview Table 60. Ximbio Anti-PD-1 MAb Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Ximbio Anti-PD-1 MAb Product Portfolio Table 62. Ximbio Recent Development Table 63. Sino Biological Company Information Table 64. Sino Biological Business Overview Table 65. Sino Biological Anti-PD-1 MAb Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Sino Biological Anti-PD-1 MAb Product Portfolio Table 67. Sino Biological Recent Development Table 68. OriGene Technologies Company Information Table 69. OriGene Technologies Business Overview Table 70. OriGene Technologies Anti-PD-1 MAb Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. OriGene Technologies Anti-PD-1 MAb Product Portfolio Table 72. OriGene Technologies Recent Development Table 73. Leinco Technologies Company Information Table 74. Leinco Technologies Business Overview Table 75. Leinco Technologies Anti-PD-1 MAb Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Leinco Technologies Anti-PD-1 MAb Product Portfolio Table 77. Leinco Technologies Recent Development Table 78. Elabscience Company Information Table 79. Elabscience Business Overview Table 80. Elabscience Anti-PD-1 MAb Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Elabscience Anti-PD-1 MAb Product Portfolio Table 82. Elabscience Recent Development Table 83. BioVision Company Information Table 84. BioVision Business Overview Table 85. BioVision Anti-PD-1 MAb Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. BioVision Anti-PD-1 MAb Product Portfolio Table 87. BioVision Recent Development Table 88. North America Anti-PD-1 MAb Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 89. North America Anti-PD-1 MAb Market Size by Country (2021-2026) & (US$ Million) Table 90. North America Anti-PD-1 MAb Market Share by Country (2021-2026) Table 91. North America Anti-PD-1 MAb Market Size Forecast by Country (2027-2032) & (US$ Million) Table 92. North America Anti-PD-1 MAb Market Share Forecast by Country (2027-2032) Table 93. Europe Anti-PD-1 MAb Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 94. Europe Anti-PD-1 MAb Market Size by Country (2021-2026) & (US$ Million) Table 95. Europe Anti-PD-1 MAb Market Share by Country (2021-2026) Table 96. Europe Anti-PD-1 MAb Market Size Forecast by Country (2027-2032) & (US$ Million) Table 97. Europe Anti-PD-1 MAb Market Share Forecast by Country (2027-2032) Table 98. Asia-Pacific Anti-PD-1 MAb Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. Asia-Pacific Anti-PD-1 MAb Market Size by Country (2021-2026) & (US$ Million) Table 100. Asia-Pacific Anti-PD-1 MAb Market Share by Country (2021-2026) Table 101. Asia-Pacific Anti-PD-1 MAb Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. Asia-Pacific Anti-PD-1 MAb Market Share Forecast by Country (2027-2032) Table 103. Latin America Anti-PD-1 MAb Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. Latin America Anti-PD-1 MAb Market Size by Country (2021-2026) & (US$ Million) Table 105. Latin America Anti-PD-1 MAb Market Share by Country (2021-2026) Table 106. Latin America Anti-PD-1 MAb Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. Latin America Anti-PD-1 MAb Market Share Forecast by Country (2027-2032) Table 108. Middle East & Africa Anti-PD-1 MAb Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Middle East & Africa Anti-PD-1 MAb Market Size by Country (2021-2026) & (US$ Million) Table 110. Middle East & Africa Anti-PD-1 MAb Market Share by Country (2021-2026) Table 111. Middle East & Africa Anti-PD-1 MAb Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Middle East & Africa Anti-PD-1 MAb Market Share Forecast by Country (2027-2032) Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Anti-PD-1 MAb Product Image Figure 3. Global Anti-PD-1 MAb Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Anti-PD-1 MAb Market Size (2021-2032) & (US$ Million) Figure 5. Global Anti-PD-1 MAb Market Share by Region: 2025 VS 2032 Figure 6. Global Anti-PD-1 MAb Market Share by Region (2021-2032) Figure 7. North America Anti-PD-1 MAb Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Anti-PD-1 MAb Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Anti-PD-1 MAb Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Anti-PD-1 MAb Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Anti-PD-1 MAb Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. 1mg Image Figure 13. Global 1mg Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. 2.5mg Image Figure 15. Global 2.5mg Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Others Image Figure 17. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Anti-PD-1 MAb Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Anti-PD-1 MAb Market Share by Type 2025 VS 2032 Figure 20. North America Anti-PD-1 MAb Market Size Share by Type (2021-2032) Figure 21. Europe Anti-PD-1 MAb Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Anti-PD-1 MAb Market Size Share by Type (2021-2032) Figure 23. Latin America Anti-PD-1 MAb Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Anti-PD-1 MAb Market Size Share by Type (2021-2032) Figure 25. Pharmaceutical Image Figure 26. Global Pharmaceutical Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Research Image Figure 28. Global Research Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Other Image Figure 30. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global Anti-PD-1 MAb Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Anti-PD-1 MAb Market Share by Application 2025 VS 2032 Figure 33. North America Anti-PD-1 MAb Market Size Share by Application (2021-2032) Figure 34. Europe Anti-PD-1 MAb Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific Anti-PD-1 MAb Market Size Share by Application (2021-2032) Figure 36. Latin America Anti-PD-1 MAb Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa Anti-PD-1 MAb Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 Anti-PD-1 MAb Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America Anti-PD-1 MAb Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America Anti-PD-1 MAb Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America Anti-PD-1 MAb Market Share by Country (2021-2032) Figure 43. Europe Anti-PD-1 MAb Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe Anti-PD-1 MAb Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Anti-PD-1 MAb Market Share by Country (2021-2032) Figure 46. Asia-Pacific Anti-PD-1 MAb Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific Anti-PD-1 MAb Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific Anti-PD-1 MAb Market Share by Country (2021-2032) Figure 49. Latin America Anti-PD-1 MAb Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America Anti-PD-1 MAb Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Anti-PD-1 MAb Market Share by Country (2021-2032) Figure 52. Middle East & Africa Anti-PD-1 MAb Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa Anti-PD-1 MAb Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa Anti-PD-1 MAb Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • 1mg
  • 2.5mg
  • Others
Applications
  • Pharmaceutical
  • Research
  • Other
Companies covered
  • Thermo Fisher Scientific
  • Merck KGaA
  • Ximbio
  • Sino Biological
  • OriGene Technologies
  • Leinco Technologies
  • Elabscience
  • BioVision

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Anti-PD-1 MAb Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Anti-PD-1 MAb Market Size by Region (2021-2032)
  5. 1.4.1 Global Anti-PD-1 MAb Market Size by Region (2021-2026)
  6. 1.4.2 Global Anti-PD-1 MAb Market Size by Region (2027-2032)
  7. 1.5 Key Regions Anti-PD-1 MAb Market Size (2021-2032)
  8. 1.5.1 North America Anti-PD-1 MAb Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Anti-PD-1 MAb Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Anti-PD-1 MAb Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Anti-PD-1 MAb Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Anti-PD-1 MAb Market Size Growth Rate (2021-2032)
2 Anti-PD-1 MAb Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 1mg
  3. 2.1.2 2.5mg
  4. 2.1.3 Others
  5. 2.2 Global Anti-PD-1 MAb Market Size by Type
  6. 2.2.1 Global Anti-PD-1 MAb Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Anti-PD-1 MAb Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Anti-PD-1 MAb Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Anti-PD-1 MAb Market Size by Regions
  10. 2.3.1 North America Anti-PD-1 MAb Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Anti-PD-1 MAb Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Anti-PD-1 MAb Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Anti-PD-1 MAb Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Anti-PD-1 MAb Market Size Breakdown by Type (2021-2026)
3 Anti-PD-1 MAb Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Pharmaceutical
  3. 3.1.2 Research
  4. 3.1.3 Other
  5. 3.2 Global Anti-PD-1 MAb Market Size by Application
  6. 3.2.1 Global Anti-PD-1 MAb Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Anti-PD-1 MAb Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Anti-PD-1 MAb Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Anti-PD-1 MAb Market Size by Regions
  10. 3.3.1 North America Anti-PD-1 MAb Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Anti-PD-1 MAb Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Anti-PD-1 MAb Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Anti-PD-1 MAb Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Anti-PD-1 MAb Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Anti-PD-1 MAb Industry Trends
  2. 4.2 Anti-PD-1 MAb Industry Drivers
  3. 4.3 Anti-PD-1 MAb Industry Opportunities and Challenges
  4. 4.4 Anti-PD-1 MAb Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Anti-PD-1 MAb Revenue (2021-2026)
  2. 5.2 Global Anti-PD-1 MAb Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Anti-PD-1 MAb Key Company Headquarters & Area Served
  4. 5.4 Global Anti-PD-1 MAb Company, Product Type & Application
  5. 5.5 Global Anti-PD-1 MAb Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Anti-PD-1 MAb Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Anti-PD-1 MAb Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Anti-PD-1 MAb Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Thermo Fisher Scientific
  2. 6.1.1 Thermo Fisher Scientific Company Information
  3. 6.1.2 Thermo Fisher Scientific Business Overview
  4. 6.1.3 Thermo Fisher Scientific Anti-PD-1 MAb Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Thermo Fisher Scientific Anti-PD-1 MAb Product Portfolio
  6. 6.1.5 Thermo Fisher Scientific Recent Developments
  7. 6.2 Merck KGaA
  8. 6.2.1 Merck KGaA Company Information
  9. 6.2.2 Merck KGaA Business Overview
  10. 6.2.3 Merck KGaA Anti-PD-1 MAb Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Merck KGaA Anti-PD-1 MAb Product Portfolio
  12. 6.2.5 Merck KGaA Recent Developments
  13. 6.3 Ximbio
  14. 6.3.1 Ximbio Company Information
  15. 6.3.2 Ximbio Business Overview
  16. 6.3.3 Ximbio Anti-PD-1 MAb Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Ximbio Anti-PD-1 MAb Product Portfolio
  18. 6.3.5 Ximbio Recent Developments
  19. 6.4 Sino Biological
  20. 6.4.1 Sino Biological Company Information
  21. 6.4.2 Sino Biological Business Overview
  22. 6.4.3 Sino Biological Anti-PD-1 MAb Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Sino Biological Anti-PD-1 MAb Product Portfolio
  24. 6.4.5 Sino Biological Recent Developments
  25. 6.5 OriGene Technologies
  26. 6.5.1 OriGene Technologies Company Information
  27. 6.5.2 OriGene Technologies Business Overview
  28. 6.5.3 OriGene Technologies Anti-PD-1 MAb Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 OriGene Technologies Anti-PD-1 MAb Product Portfolio
  30. 6.5.5 OriGene Technologies Recent Developments
  31. 6.6 Leinco Technologies
  32. 6.6.1 Leinco Technologies Company Information
  33. 6.6.2 Leinco Technologies Business Overview
  34. 6.6.3 Leinco Technologies Anti-PD-1 MAb Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Leinco Technologies Anti-PD-1 MAb Product Portfolio
  36. 6.6.5 Leinco Technologies Recent Developments
  37. 6.7 Elabscience
  38. 6.7.1 Elabscience Company Information
  39. 6.7.2 Elabscience Business Overview
  40. 6.7.3 Elabscience Anti-PD-1 MAb Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Elabscience Anti-PD-1 MAb Product Portfolio
  42. 6.7.5 Elabscience Recent Developments
  43. 6.8 BioVision
  44. 6.8.1 BioVision Company Information
  45. 6.8.2 BioVision Business Overview
  46. 6.8.3 BioVision Anti-PD-1 MAb Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 BioVision Anti-PD-1 MAb Product Portfolio
  48. 6.8.5 BioVision Recent Developments
7 North America
  1. 7.1 North America Anti-PD-1 MAb Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Anti-PD-1 MAb Market Size by Country (2021-2026)
  3. 7.3 North America Anti-PD-1 MAb Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Anti-PD-1 MAb Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Anti-PD-1 MAb Market Size by Country (2021-2026)
  3. 8.3 Europe Anti-PD-1 MAb Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Anti-PD-1 MAb Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Anti-PD-1 MAb Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Anti-PD-1 MAb Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Anti-PD-1 MAb Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Anti-PD-1 MAb Market Size by Country (2021-2026)
  3. 10.3 South America Anti-PD-1 MAb Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Anti-PD-1 MAb Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Anti-PD-1 MAb Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Anti-PD-1 MAb Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst